Belvedere Trading
ETON icon

Belvedere Trading’s Eton Pharmaceutcials ETON Stock Holding History

Belvedere Trading’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24,000
Closed -$94K – 422
2022
Q1 		$94K Buy
+24,000
New +$94.4K ﹤0.01% 340

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Belvedere Trading's ETON Position: Q2 2022 in Review

Belvedere Trading sold out of Eton Pharmaceutcials (ETON) in Q2 2022, closing a stake of 10,876 shares — an estimated $43K sold.

Belvedere Trading first reported a position in ETON in Q3 2021 and held it in 2 quarters. The position peaked at $107K in Q3 2021. 29 funds tracked by Wall St. Rank hold ETON as of Q2 2022.

  • Belvedere Trading reported no remaining Eton Pharmaceutcials position as of Q2 2022 after selling out during the quarter.
  • Belvedere Trading sold 10,876 Eton Pharmaceutcials shares in Q2 2022, an estimated $43K.
  • Belvedere Trading first reported a position in Eton Pharmaceutcials in Q3 2021 and held it in 2 quarters.
  • Belvedere Trading's Eton Pharmaceutcials position peaked at $107K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2022.

Based on Belvedere Trading's 13F filing for Q2 2022, filed 21 Jul 2022.